ImClone (Nasdaq: IMCL) : IMCL, an oncology care company, closed at $46.22. IMCL's Erbutux Phase 3 FLEX ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE